Irbesartan [`Avapro'; Bristol-Myers Squibb, Sanofi-Synthélabo] has been approved in Canada

Source: Inpharma, Volume 1, Number 1365, 2002 , pp. 22-22(1)

Publisher: Adis International

Keywords: Bristol-Myers-Squibb; Development-status; Diabetic-nephropathies, treatment; Hypertension; Irbesartan, therapeutic use; Kidney-disorders, treatment; Product-approvals; Sanofi-Synthelabo; Trial-result-clinical; Type-2-diabetes-mellitus

Language: English

Document Type: Short communication

Publication date: 2002-01-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers